Fluidigm Corporation has developed a new web microsite that provides a comprehensive introduction to the rapidly expanding field of single cell gene expression profiling.
Historically, gene expression profiling of single cells, such as stem cells, circulating tumour and FFPE has been difficult and expensive to perform. Now, however, results from single-cell samples can be obtained easily and inexpensively using the Fluidigm's BioMark™ System and the company's Dynamic Array™ integrated fluidic circuits (IFCs). Dynamic Array IFCs are ideally suited for high-throughput cell-line studies to determine individual cell behaviour in a homozygous population.
Visitors to http://www.fluidigm.com/email/singlecell/ePromo_Landing.html
can gain an understanding of the technology, find out how international scientists using Fluidigm Dynamic Array chips are accelerating their research and evaluate whether IFC technology is right for their project.
A five minute audiovisual presentation provides an informative introduction to how IFC technology is now providing a practical means of studying single cells A wide selection of downloadable customer conference posters, peer reviewed publications, success stories and application notes describe the technology in action and the benefits it is delivering to leading laboratories around the world.
Fluidigm develops, manufactures and markets proprietary Integrated Fluidic Circuit (IFC) systems that significantly improve productivity in life science research. Fluidigm's IFCs enable the simultaneous performance of thousands of sophisticated biochemical measurements in extremely minute volumes. These "integrated circuits for biology" are made possible by miniaturizing and integrating liquid handling components on a single microfabricated microfluidic device. Fluidigm's IFC systems, consisting of instrumentation, software and single-use IFCs, increase throughput, decrease costs and enhance sensitivity compared to conventional laboratory systems. Fluidigm products have not been cleared or approved by the Food and Drug Administration for use as a diagnostic and are only available for research use.
* Fluidigm, the Fluidigm logo, BioMark, Dynamic Arrayand Digital Array are trademarks of Fluidigm Corporation and all other trademarks are the property of their respective owners.